Husain, Shajanie B.
HRN: 12-92-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2022
CEFUROXIME 500MG (TAB)
06/21/2022
06/23/2022
ORAL
500mg
BID
S/P Suction Curettage
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Duration Further Investigation
Overall appropriateness: No Further Investigation